Iovance Biotherapeutics Inc (IOVA)

Sep 25, 2026

Iovance Biotherapeutics, Inc. (IOVA) Options Chain - Yahoo! Finance Canada

Sep 25, 2026

Sep 25, 2026

IOVA Stock Hits Fresh 52-Week Peak On UBS Target Hike, Melanoma Sector Optimism - Stocktwits

Sep 25, 2026

Sep 25, 2026

Iovance Biotherapeutics stock hits 52-week high at 10.98 USD - Investing.com

Sep 25, 2026

Sep 25, 2026

Iovance Biotherapeutics Price Target Announced at $15.00/Share by Goldman Sachs - Moomoo

Sep 25, 2026

Sep 25, 2026

After IOVA Stock’s Best Day In 2 Years, Analyst Sees Over 300% Upside: Here’s Why - Stocktwits

Sep 25, 2026

Sep 24, 2026

Why Iovance Biotherapeutics Stock Was on Fire Today - The Globe and Mail

Sep 24, 2026

Sep 24, 2026

IOVA Reinstated by Goldman Sachs -- Buy Rating with Price Target of $15.00 - GuruFocus

Sep 24, 2026

Sep 24, 2026

Goldman Sachs Reinstates Buy on Iovance Biotherapeutics (IOVA) w - GuruFocus

Sep 24, 2026

Sep 23, 2026

IOVA Stock Quote Price and Forecast - CNN

Sep 23, 2026

Sep 22, 2026

Iovance Biotherapeutics, Inc. (IOVA) stock price, news, quote and history - Yahoo Finance UK

Sep 22, 2026

Sep 22, 2026

Iovance Biotherapeutics, Inc. (IOVA) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 22, 2026

Sep 22, 2026

IOVA Stock Slump Takes Wall Street, Retail By Surprise — Here’s Why - Stocktwits

Sep 22, 2026

Sep 22, 2026

Iovance Biotherapeutics Inc (IOVA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Sep 22, 2026

Sep 21, 2026

Iovance Biotherapeutics stock extends rally after strong earnings and cancer therapy momentum - AD HOC NEWS

Sep 21, 2026

Sep 21, 2026

Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate - Zacks Investment Research

Sep 21, 2026

Sep 21, 2026

Iovance Biotherapeutics Stock: 6 Straight Green Days, Up 26% - Trefis

Sep 21, 2026

Sep 19, 2026

Why Did Iovance Biotherapeutics (IOVA) Move Today? - Yahoo Finance

Sep 19, 2026

Sep 19, 2026

Iovance Biotherapeutics (IOVA) Is Up 19.2% After Record Q2 Amtagvi Revenue And TIL Pipeline Expansion - Yahoo Finance

Sep 19, 2026

Sep 19, 2026

Iovance Biotherapeutics (IOVA) Stock Fair Value Edges Higher On Amtagvi Margin Progress - Yahoo Finance

Sep 19, 2026

Sep 19, 2026

Is Iovance Biotherapeutics (IOVA) Trading At A Premium To Sales? - Yahoo Finance

Sep 19, 2026

Sep 18, 2026

Iovance Biotherapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Moomoo

Sep 18, 2026

Sep 18, 2026

Iovance Biotherapeutics (IOVA) Stock Forum and Discussion - Moomoo

Sep 18, 2026

Sep 18, 2026

Iovance Biotherapeutics (IOVA) Puts Buyer Nets 64% Gain as Marke - GuruFocus

Sep 18, 2026

Sep 18, 2026

Iovance Biotherapeutics (IOVA) Stock Analysis: Unpacking the 65.7% Revenue Growth Potential - DirectorsTalk Interviews

Sep 18, 2026

Sep 17, 2026

$Iovance Biotherapeutics (IOVA.US)$ - Moomoo

Sep 17, 2026

Sep 17, 2026

$Iovance Biotherapeutics (IOVA.US)$ Talking a profit here and waiting for it to come down closer to 9 ema - Moomoo

Sep 17, 2026

Sep 17, 2026

IOVA Maintained by Barclays -- Price Target Raised to $15.00 - GuruFocus

Sep 17, 2026

Sep 17, 2026

Barclays Maintains Iovance Biotherapeutics(IOVA.US) With Buy Rating, Raises Target Price to $15 - Moomoo

Sep 17, 2026

Sep 17, 2026

IOVA Stock Has Gained More Than 21% In Four Sessions, And Barclays Sees Another 52% Upside PotentialHere’s Why - finance.yahoo.com

Sep 17, 2026

Sep 14, 2026

Iovance Biotherapeutics stock hits 52-week high at 9.36 USD By Investing.com - Investing.com Nigeria

Sep 14, 2026

Sep 14, 2026

Iovance Biotherapeutics stock hits 52-week high at 9.36 USD - Investing.com

Sep 14, 2026

Sep 12, 2026

Why Did IOVA, AMLX And COP Stocks Surge To 52-Week Highs Today? - Stocktwits

Sep 12, 2026

Sep 10, 2026

Why Did IOVA Stock Gain Pre-Market Today? - Stocktwits

Sep 10, 2026

Sep 10, 2026

Iovance Biotherapeutics' Chief Regulatory Officer Reports RSU Vesting and Tax Withholding Transactions - Kalkine Media

Sep 10, 2026

Sep 10, 2026

Iovance at Wells Fargo conference: sales momentum lifts outlook By Investing.com - Investing.com Australia

Sep 10, 2026

Sep 09, 2026

Iovance Biotherapeutics (IOVA) Slips 3.10% to $8.43 as Support at $8.01 Comes Into FocusAlgorithmic Stock Picks - careplusvn.com

Sep 09, 2026

Sep 08, 2026

Iovance Biotherapeutics stock trends on sector momentum, Q2 beat - scanx.trade

Sep 08, 2026

Sep 08, 2026

Why Is IOVA Stock Falling Today? - Stocktwits

Sep 08, 2026

Sep 08, 2026

NFLX: Netflix Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

Sep 08, 2026

Sep 06, 2026

How Iovance Biotherapeutics Inc. (IOVA) Affects Rotational Strategy Timing - Stock Traders Daily

Sep 06, 2026

Sep 05, 2026

Iovance Biotherapeutics Stock Price Forecast. Should You Buy IOVA? - StockInvest.us

Sep 05, 2026

Sep 04, 2026

Iovance Biotherapeutics, Inc. (IOVA) Latest Press Releases & Corporate News - Yahoo Finance

Sep 04, 2026

Sep 04, 2026

Iovance Biotherapeutics, Inc. (IOVA) Latest Stock News & Headlines - Yahoo Finance

Sep 04, 2026

Sep 04, 2026

Iovance Biotherapeutics to Present at Upcoming Conferences - The Manila Times

Sep 04, 2026

Sep 01, 2026

Iovance Biotherapeutics (IOVA) Stands Out with Strong Quant Rati - GuruFocus

Sep 01, 2026

Aug 29, 2026

Iovance Biotherapeutics (IOVA) Wins FDA Trial Clearance, Is The Stock Still 54% Undervalued? - sahmcapital.com

Aug 29, 2026

Aug 27, 2026

Iovance Biotherapeutics Inc. (IOVA) Peer Comparison – Compare with Others - Value Research

Aug 27, 2026

Aug 27, 2026

Zacks Industry Outlook Halozyme, Repligen, Iovance, Arcutis and Precigen - Eastern Progress

Aug 27, 2026